AbCellera Biologics Inc.

ABCL· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$11.12-9.41%

2026-11-02

Financials

Valuation Metrics

AbCellera Biologics Inc.'s Market Cap is $3.39B. At end of 2025 it was $1.02B. Ranked #1551 of 3,118 in US market (top 50%), #535 of 1,474 on NASDAQ (top 36%), #89 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 34%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$3.39B	US#1,551/3,118 Sec#89/265
Revenue	$66M	US#2,720/3,118 Sec#138/265
Net Income	$-165M	US—/3,118 Sec—/265
Total Assets	$1.31B	US#2,330/3,118 Sec#76/265
Net Assets	$896M	US#1,835/3,118 Sec#73/265
Value
P/B	3.79x	US#2,090/3,118 Sec#132/265
P/S	51.29x	US#2,924/3,118 Sec#169/265
FCF Yield	-4.19%	US—/3,118 Sec—/265
Profitability
ROE	-18.38%	US#2,458/3,118 Sec#98/265
ROA	-12.59%	US#2,694/3,118 Sec#108/265
Op. Margin	-340.25%	US#2,766/3,118 Sec#147/265
Revenue Growth	101.28%	US#94/3,118 Sec#33/265
Financial Health
Debt Ratio	45.93%	US#523/3,118 Sec#136/265
Total Debt	$136M	US#2,344/3,118 Sec#106/265
FCF	$-142M	US#2,701/3,118 Sec#174/265
Cash	$120M	US#2,090/3,118 Sec#156/265
Current Ratio	12.77x	US#189/3,118 Sec#59/265
Performance
1Y Return	100.27%	US#85/3,118 Sec#25/265
1M Return	-19.10%	US#2,685/3,118 Sec#208/265
From 52W High	-26.00%	US#1,385/3,118 Sec#74/265
1Y MDD	-42.92%	US#2,325/3,118 Sec#153/265
Trading
Volume	2,834,601 shares	US#548/3,118 Sec#41/265
Trading Value	$33M	US#1,367/3,118 Sec#88/265
Per Share
EPS	$-0.54	US—/3,118 Sec—/265
BPS	$2.93	US#2,488/3,118 Sec#161/265